Alvotech further strengthens liquidity by securing term loan facility of $75 million

December 31, 2027, led by GoldenTree Asset Management — Follows recent $165m equity raise strengthening cash position — Including equity financing and undrawn loan facility, Alvotech has secured ...

Alvotech’s US$240 Million Capital Boost Might Change The Case For Investing In Alvotech (ALVO)

Alvotech recently amended its credit agreement to add a new US$75 million term loan facility led by GoldenTree Asset ...

Alvotech (ALVO): 10 Penny Stocks With Explosive Growth Potential

Alvotech (NASDAQ:ALVO) is one of the penny stocks with explosive growth potential. On June 18, Alvotech closed its ...

Biotech firm Alvotech expands capital access with $75M term loan facility

Alvotech (ALVO) announced an amendment to its existing credit agreement, securing a new term loan facility of up to $75M. The financing was led by long-term partner GoldenTree Asset Management LP ...

Alvotech prices $85M stock offering, plans additional raise via private placement

Alvotech (ALVO) priced its previously announced underwritten public offering of 22.67M ordinary shares at $3.75 per share, expecting to raise about $85M in gross proceeds. The global biosimilars ...

Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares

Alvotech anticipates the gross proceeds from the Offering and concurrent private placement to be approximately $125 million. The allocation of ordinary shares between the Offering and concurrent ...

Alvotech (ALVO) Gets a Sell from Barclays

Barclays analyst Glen Santangelo assigned a Sell rating to Alvotech today and set a price target of $4.00. Claim 55% Off TipRanks. Unlock trusted, data-backed investing tools with ...
Nasdaq

Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer

Appointment of Linda Jónsdóttir as Chief Financial Officer strengthens Alvotech's leadership team with her extensive experience across multiple industries. Joel Morales will continue to support the ...
Nasdaq

Why Shares of Alvotech Are Jumping Friday

Friday's bounce back is a reaction to what is being viewed as the market's overreaction the day before. While the FDA did issue a complete response to a second Biologics License Application (BLA) for ...
FiercePharma

AbbVie, Alvotech settle Humira patent and trade secrets disputes, teeing up another biosim rollout next year

Alvotech, the Icelandic holdout battling AbbVie in court over its Humira biosimilar, has reached an accord with the U.S. pharma giant. With a settlement in place, the companies are putting all patent ...
Benzinga.com

Alvotech Strengthens Biosimilar Portfolio With $27 Million Xbrane R&D Deal

Alvotech acquires Xbrane's R&D operations and biosimilar candidate XB003 for ~$27M, expanding into Sweden's life sciences sector. Xbrane retains key preclinical assets, strengthens finances, and ...
Reuters

Alvotech settles with J&J to launch Stelara biosimilar in Europe, Canada

Feb 15 (Reuters) - Alvotech (ALVO.O), opens new tab said on Thursday it has reached settlement agreements with Johnson & Johnson (JNJ.N), opens new tab for launching a biosimilar of the pharmaceutical ...